Cite
Weekly chemotherapy as first line treatment in frail head and neck cancer patients in the immunotherapy era
MLA
Andrea Botticelli, et al. “Weekly Chemotherapy as First Line Treatment in Frail Head and Neck Cancer Patients in the Immunotherapy Era.” Journal of Translational Medicine, vol. 19, no. 1, July 2021, pp. 1–7. EBSCOhost, https://doi.org/10.1186/s12967-021-02975-3.
APA
Andrea Botticelli, Giulia Pomati, Alessio Cirillo, Giulia Mammone, Fabio Ciurluini, Bruna Cerbelli, Paolo Sciattella, Massimo Ralli, Umberto Romeo, Francesca De Felice, Carlo Catalano, Francesco Vullo, Marco Della Monaca, Sasan Amirhassankhani, Silverio Tomao, Valentino Valentini, Marco De Vincentiis, Vincenzo Tombolini, Carlo Della Rocca, … Paolo Marchetti. (2021). Weekly chemotherapy as first line treatment in frail head and neck cancer patients in the immunotherapy era. Journal of Translational Medicine, 19(1), 1–7. https://doi.org/10.1186/s12967-021-02975-3
Chicago
Andrea Botticelli, Giulia Pomati, Alessio Cirillo, Giulia Mammone, Fabio Ciurluini, Bruna Cerbelli, Paolo Sciattella, et al. 2021. “Weekly Chemotherapy as First Line Treatment in Frail Head and Neck Cancer Patients in the Immunotherapy Era.” Journal of Translational Medicine 19 (1): 1–7. doi:10.1186/s12967-021-02975-3.